Upexi Approves Share Buyback Program Worth Up to $50 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 13 2025
0mins
Should l Buy UPXI?
Source: NASDAQ.COM
Stock Repurchase Authorization: Upexi, Inc. has announced authorization to repurchase up to $50 million of its common stock to enhance shareholder value.
Management's Perspective: CEO Allan Marshall stated that the repurchase program will be utilized when it represents an attractive return on capital without hindering strategic growth or treasury strength.
Market Activity: In pre-market trading, Upexi shares were priced at $3.41, reflecting a 1.17% increase on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UPXI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UPXI
Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.090
Low
6.00
Averages
6.00
High
6.00
Current: 1.090
Low
6.00
Averages
6.00
High
6.00
About UPXI
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Issuance Agreement: Upexi has entered into a definitive agreement with a single institutional investor for the sale of 6,337,000 shares of common stock and warrants, priced at $1.17 per share, expected to close on February 9, 2026, with proceeds allocated for working capital and general corporate purposes.
- Warrant Terms: The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire in five years, with a forced conversion price of $5.00, indicating the company's confidence in future stock price appreciation.
- Existing Warrant Amendments: Upexi has agreed to amend previously issued warrants for 3,289,474 shares from December 2025, reducing the exercise price from $4.00 to $2.83 and the redemption price trigger from $8.50 to $7.00, aimed at enhancing investor appeal.
- Compliance and Registration Statement: The offering is made pursuant to an effective S-3 registration statement declared effective on January 8, 2026, ensuring compliance and providing transparent disclosures to investors, thereby enhancing market trust.
See More
- Earnings Call Announcement: Upexi plans to host a conference call on February 10, 2026, to report its financial results for Q2 2026, which ended on December 31, 2025, likely drawing significant investor interest.
- Call Details: The call is scheduled for 5:30 p.m. ET, with participants able to dial in at 1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International), ensuring broad accessibility for stakeholders.
- Replay Availability: For those unable to join live, a replay of the call will be available until February 24, 2026, accessible by dialing 1-844-512-2921 (U.S. Toll-Free) or 1-412-317-6671 (International), providing continued access to the information shared.
- Company Overview: Upexi is a digital asset treasury company focused on acquiring and holding Solana (SOL) in a disciplined manner, utilizing mechanisms like intelligent capital issuance and staking, currently holding over two million SOL, positioning itself strategically in the market.
See More
- Investor Conference Schedule: Upexi will participate in the 12th Annual Alpha North Capital Event from January 16-18, 2026, at the Grand Hyatt Baha Mar in the Bahamas, with Chief Strategy Officer Brian Rudick attending to enhance investor engagement.
- Virtual Conference Participation: The company will also attend the Sidoti Micro-Cap Virtual Conference on January 21-22, 2026, where Brian Rudick will present on January 22 from 11:30 AM to 12:00 PM EST, further showcasing the company's strategic direction.
- Digital Asset Strategy: Upexi currently holds over 2 million Solana (SOL) and aims to increase its digital asset value through intelligent capital issuance, staking, and discounted locked token purchases, positioning itself prudently in various market environments.
- Brand Development: In addition to digital assets, Upexi focuses on the development, manufacturing, and distribution of consumer products, demonstrating its strategic diversification in business operations.
See More
- Conference Participation: Upexi will attend the 12th Annual Alpha North Capital Event from January 16-18, 2026, at the Grand Hyatt Baha Mar in the Bahamas, with Chief Strategy Officer Brian Rudick participating to enhance the company's visibility among investors.
- Virtual Conference: Additionally, Upexi will participate in the Sidoti Micro-Cap Virtual Conference on January 21-22, 2026, where Brian Rudick will present on January 22 from 11:30 AM to 12:00 PM EST, showcasing the company's strategic positioning and market insights.
- Digital Asset Strategy: As a Solana-focused digital asset treasury company, Upexi currently holds over 2 million SOL and aims to enhance value through intelligent capital issuance, staking, and discounted locked token purchases, thereby boosting investor confidence.
- Brand Development: Beyond digital assets, Upexi specializes in the development, manufacturing, and distribution of consumer products, demonstrating its diversified business model and competitive edge in the market.
See More
- Milestone Moment: Upexi will ring the Nasdaq Closing Bell on January 5, 2026, at the Nasdaq MarketSite in Times Square, New York, marking a significant milestone that enhances the company's visibility in the Solana ecosystem and attracts investor interest.
- Leadership Participation: CEO Allan Marshall will lead the company's leadership team, Board members, and employees in this important ceremony, showcasing the team's cohesion and commitment to the company's growth, which will further boost internal morale.
- Digital Asset Strategy: Upexi currently holds over 2 million SOL and aims to enhance value through intelligent capital issuance, staking, and discounted locked token purchases, demonstrating its foresight and risk management capabilities in the digital asset space.
- Brand Development Focus: In addition to digital assets, Upexi specializes in the development, manufacturing, and distribution of consumer products, aiming to enhance market competitiveness and profitability through a diversified business model.
See More
- Capital Raising Optimization: Upexi filed an S-3 registration statement with the SEC on December 22, 2025, planning to cancel its unused equity line of credit upon effectiveness, thereby enhancing capital access efficiency and reducing transaction costs.
- Increased Flexibility: By replacing the equity line, Upexi will have the flexibility to raise capital at management's discretion, optimizing timing and pricing in alignment with its Solana asset strategy.
- Market Positioning: Currently holding over 2 million Solana (SOL), Upexi aims to acquire more through intelligent capital issuance, staking, and discounted locked token purchases, positioning itself competitively in various market environments.
- Brand Development: In addition to digital asset management, Upexi focuses on the development, manufacturing, and distribution of consumer products, showcasing its strategic diversification and enhancing its influence in the consumer market.
See More








